American College of Clinical Pharmacy
      Search      Cart

Pharmacogenomic Testing: Opportunities and Best Practices for Pharmacists

Saturday, October 26, 2019 from 9:45 AM to 11:15 AM EDT at 3rd Floor: Mercury Ballroom

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-19-157-L04-P
Activity Type: A Knowledge-Based Activity

  • Christine M. Walko, Pharm.D., BCOP, FCCPModerator: Christine M. Walko, Pharm.D., BCOP, FCCP
    Associate Member, Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, Florida
      View Biography

Pharmacogenomics in Mental health: Developing an Evidence-based Practice
9:45 AM

  • Teresa T. Ho, Pharm.D., BCPSSpeaker: Teresa T. Ho, Pharm.D., BCPS
    Assistant Professor, Department of Pharmacy Practice; Assistant Professor, College of Medicine Internal Medicine, University of South Florida, Tampa, Florida
      View Biography

Learning Objectives
1. Review the most clinically relevant gene-drug pairs the influence psychiatric medication dosing.
2. Describe the challenges of translating pharmacogenomic testing into psychiatric drug therapy management, including test ordering, insurance billing, documentation of results and patient education.
3. Identify available resources and guidelines to design best practices for translation into clinical practice.
Integrating Pharmacogenomics into Comprehensive Medication Management
10:15 AM

  • James Kevin Hicks, Pharm.D., Ph.D.Speaker: James Kevin Hicks, Pharm.D., Ph.D.
    Personalized Medicine Specialist, Moffitt Cancer Center, Tampa, Florida
      View Biography

Learning Objectives
1. Review clinically relevant genes commonly included on pharmacogenomic testing panels.
2. Identify primary literature and clinical guidelines to inform practice recommendations and medical therapy management decisions.
3. Apply evidence-based medicine to pharmacogenomic-guided therapy in a case-based patient scenario.
The Role of the Pharmacist in the 23andMe Testing Era
10:45 AM

  • Henry  Dunnenberger, IV, Pharm.D.Speaker: Henry Dunnenberger, IV, Pharm.D.
    Director - Pharmacogenomics, NorthShore University HealthSystem, Evanston, Illinois
      View Biography

Learning Objectives
1. Describe the types of genetic information being provided through large panel, direct to consumer genetic testing.
2. Identify potential opportunities for pharmacy to enhance the clinical value of the information provided in these tests when approached.
3. Formulate recommendations for counseling content and identify additional resources appropriate for patients looking for understanding of their test results.